Correlation Between Biotechnology Portfolio and Money Market

Can any of the company-specific risk be diversified away by investing in both Biotechnology Portfolio and Money Market at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Portfolio and Money Market into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Portfolio Biotechnology and Money Market Obligations, you can compare the effects of market volatilities on Biotechnology Portfolio and Money Market and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Portfolio with a short position of Money Market. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Portfolio and Money Market.

Diversification Opportunities for Biotechnology Portfolio and Money Market

0.0

Correlation Coefficient

Biotechnology Portfolio  Money Market

Pay attention - limited upside

The 3 months correlation between Biotechnology and Money is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and Money Market Obligations in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Money Market Obligations and Biotechnology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Portfolio Biotechnology are associated (or correlated) with Money Market. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Money Market Obligations has no effect on the direction of Biotechnology Portfolio i.e., Biotechnology Portfolio and Money Market go up and down completely randomly.

Pair Corralation between Biotechnology Portfolio and Money Market

Assuming the 90 days horizon Biotechnology Portfolio Biotechnology is expected to generate 10.04 times more return on investment than Money Market. However, Biotechnology Portfolio is 10.04 times more volatile than Money Market Obligations. It trades about 0.02 of its potential returns per unit of risk. Money Market Obligations is currently generating about 0.13 per unit of risk. If you would invest  1,848  in Biotechnology Portfolio Biotechnology on October 6, 2024 and sell it today you would earn a total of  57.00  from holding Biotechnology Portfolio Biotechnology or generate 3.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Biotechnology Portfolio Biotec  vs.  Money Market Obligations

Biotechnology Portfolio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Money Market Obligations

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Money Market Obligations has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Money Market is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Portfolio and Money Market

The main advantage of trading using opposite Biotechnology Portfolio and Money Market positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Portfolio position performs unexpectedly, Money Market can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Money Market will offset losses from the drop in Money Market's long position.

The idea behind Biotechnology Portfolio Biotechnology and Money Market Obligations pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.